"ASCO 2018 -The Pace of Research Quickens For Personalizing Care For Lung Cancer Patients"
Nicholas Rohs, MD, assistant professor of medicine, hematology, and medical oncology at the Icahn School of Medicine at Mount Sinai and attending physician of hematology and medical oncology at the Mount Sinai Downtown - Chelsea Center, talks about the latest developments in lung cancer care and treatment research. Dr. Rohs discusses the data presented for both branches of lung cancer; small cell and non-small cell lung cancer, and the momentum toward more personalized medicine. Dr. Rohs also explains how understanding genetic mutational status has influenced treatment strategy, promising immunotherapy and combination therapy approaches in current studies, and potential crossover therapies that may treat more than one cancer.
- Nicholas Rohs, MD, Assistant Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Attending Physician, Hematology and Medical Oncology, Mount Sinai Downtown – Chelsea Center